Cyp1a2 is essential in murine uroporphyria caused by hexachlorobenzene and iron

Toxicology and Applied Pharmacology

Volumn 162, Issue 1, 2000, Pages 60-67

  Sinclair, Peter R ^a,b   Gorman, Nadia ^a,b   Walton, Heidi S ^a,b   Bement, William J ^a   Dalton, Timothy P ^c   Sinclair, Jacqueline F ^a,b   Smith, Andrew G ^d   Nebert, Daniel W ^c  

^a VA MEDICAL CENTER   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^d UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

CYP1A2; Hexachlorobenzene; Iron; Liver; Uroporphyrin

Indexed keywords

HEXACHLOROBENZENE; IRON; UROPORPHYRINOGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ANALYSIS; MALE; MOUSE; NONHUMAN; OXIDATION; PORPHYRIA; WESTERN BLOTTING;

EID: 0033964561     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1999.8832     Document Type: Article

References (47)

1. Akhtar R. A., Smith A. G. Chromosomal linkage analysis of porphyria in mice induced by hexachlorobenzene-iron synergism. Pharmacogenetics. 8:1998;485-494.
2. Chang T. K., Gonzalez F. J., Waxman D. J. Evaluation of triacetyloleandomycin, alphanaphthoflavone and diethyldithiocarbamate as selective chemical probes for inhibition of human cytochromes P450. Arch. Biochem. Biophys. 311:1994;437-442.
3. Deam S., Elder G. H. Uroporphyria produced in mice by iron and 5-aminolevulinic acid. Biochem. Pharmacol. 41:1991;2019-2022.
4. De Matteis F. D. Porphyria cutanea tarda of the toxic and sporadic varieties. Clin. Dermatol. 16:1998;265-275.
5. De Matteis F., Harvey C., Reed C., Hempenius R. Increased oxidation of uroporphyrinogen by an inducible liver microsomal system. Biochem. J. 250:1988;161-169.
6. Den Besten C., Bennik M. H. J., Bruggeman I., Schielen P., Kuper F., Brouwer A., Koeman J. H., Vos J. G., van Bladeren P. J. The role of oxidative metabolism in hexachlorobenzene-induced porphyria and thyroid hormone homeostasis: A comparison with pentachlorobenzene in a 13-week feeding study. Toxicol. Appl. Pharmacol. 119:1993;181-194.
7. Elder G. H. Porphyria caused by hexachlorobenzene and other polyhalogenated aromatic hydrocarbons. De Matteis F. D., Aldridge W. N. Heme and Hemoproteins. 1978;157-193 Springer-Verlag, Berlin.
8. Elder G. H. Porphyria cutanea tarda. Semin. Liv. Dis. 18:1998;67-76.
9. Franklin M. R., Phillips J. D., Kushner J. P. Cytochrome P450 induction, uroporphyrinogen decarboxylase depression, porphyrin accumulation and excretion, and gender influence in a 3-week rat model of porphyria cutanea tarda. Toxicol. Appl. Pharmacol. 147:1997;288-299.
10. Franklin M. R., Phillips J. D., Kushner J. P. Effects of two cytochrome P450 3A inducers, 5-pregnen-3β-ol-20-one-16α-carbonitrile and troleandomycin, in a three-week rat model of porphyria cutanea tarda. Toxicol. Sci. 42:1998;93.
11. Gorman N., Walton H. S., Bement W. J., Honsinger C. P., Szakacs J. G., Sinclair J. F., Sinclair P. R. Role of small differences in CYP1A2 in the development of uroporphyria produced by iron and 5-aminolevulinate in C57BL/6 and SWR strains of mice. Biochem. Pharmacol. 58:1999;375-382.
12. Hahn M. E., Gasiewicz T. A., Linko P., Goldstein J. A. The role of the Ah locus in hexachlorobenzene-induced porphyria: Studies in congenic C57BL/6J mice. Biochem. J. 254:1988;245-254.
13. Hahn M. E., Goldstein J. A., Linko P., Gasiewicz T. A. Interaction of hexachlorobenzene with the receptor for 2,3,7,8-tetrachlorodibenzo-p-dioxin in vitro and in vivo. Evidence that hexachlorobenzene is a weak Ah receptor agonist. Arch. Biochem. Biophys. 270:1989;344-355.
14. Hamm J. T., Ross G. D., Richardson V. M., Diliberto J. J., Birnbaum L. S. Methoxyresorufin: An inappropriate substrate for CYP1A2 in the mouse. Biochem. Pharmacol. 56:1998;1657-1660.
15. Hornsten L., Bylund J., Oliw E. H. Dexamethasone induces bisallylic hydroxylation of polyunsaturated fatty acids by rat liver microsomes. Arch. Biochem. Biophys. 332:1996;261-268.
16. Jacobs J. M., Sinclair P. R., Bement W. J., Lambrecht R. W., Sinclair J. F., Goldstein J. A. Oxidation of uroporphyrinogen by methylcholanthrene-induced cytochrome P450. Biochem. J. 258:1989;247-253.
17. Kostrubsky V. E., Strom S. C., Wood S. G., Wrighton S. A., Sinclair P. R., Sinclair J. F. Ethanol and isopentanol increase CYP3A and CYP2E in primary cultures of human hepatocytes. Arch. Biochem. Biophys. 322:1995;516-520.
18. Lambrecht R. W., Jacobs J. M., Sinclair P. R., Sinclair J. F. Inhibition of uroporphyrinogen decarboxylase activity. The role of cytochrome P450-mediated uroporphyrinogen oxidation. Biochem. J. 269:1990;437-441.
19. Lambrecht R. W., Sinclair P. R., Gorman N., Sinclair J. F. Uroporphyrinogen oxidation catalyzed by reconstituted cytochrome P4501A2. Arch. Biochem. Biophys. 294:1992;504-510.
20. Liang H. C., Li H., McKinnon R. A., Duffy J. J., Potter S. S., Puga A., Nebert D. W. Cyp1a2(-/-) null mutant mice develop normally but show deficient drug metabolism. Proc. Natl. Acad. Sci. U.S.A. 93:1996;1671-1676.
21. Linko P., Yeowell H. N., Gasiewicz T. A., Goldstein J. A. Induction of cytochrome P-450 isozymes by hexachlorobenzene in rats and aromatic hydrocarbon (Ah)-responsive mice. J. Biochem. Toxicol. 1:1986;95-107.
22. Louis C. A., Wood S. G., Kostrubsky V., Sinclair P. R., Sinclair J. F. Synergistic increases in rat hepatic cytochrome P450s by ethanol and isopentanol. J. Pharmacol. Exp. Ther. 269:1994;838-845.
23. Louw M., Neethling A. C., Percy V. A., Carstens M., Shanley B. C. Effects of hexachlorobenzene feeding and iron overload on enzymes of haem biosynthesis and cytochrome P450 in rat liver. Clin. Sci. Mol. Med. 53:1977;111-115.
24. Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
25. Mylchreest E., Charbonneau M. Studies on the mechanism of uroporphyrinogen decarboxylase inhibition in hexachlorobenzene-induced porphyria in the female rat. Toxicol. Pharmacol. 145:1997;23-33.
26. Nerurkar P. V., Park S. S., Thomas P. E., Nims R. W., Lubet R. A. Methoxyresorufin and benzyloxyresorufin: Substrates preferentially metabolized by cytochromes P4501A2 and 2B, respectively, in the rat and mouse. Biochem. Pharmacol. 46:1993;933-943.
27. Oteiza P. I., Kleinman C. G., Demasi M., Bechara E. J. H. 5-Aminolevulinic acid induces iron release from ferritin. Arch. Biochem. Biophys. 316:1995;607-611.
28. 5. Arch. Biochem. Biophys. 251:1986;629-638.
29. Roberts A. G., Whatley S. D., Morgan R. R., Worwood M., Elder G. H. Increased frequency of the haemochromatosis Cys282Tyr mutation in sporadic porphyria cutanea tarda. Lancet. 349:1997;321-323.
30. Siersema P. D., Cleton-Soeteman M. I., de Bruijn W. C., ten Kate F. J. W., van Eijk H. G., Wilson J. H. P. Ferritin accumulation and uroporphyrin crystal formation in hepatocytes of C57BL/10 mice: A time-course study. Cell Tissue Res. 274:1993;405-412.
31. Sinclair P., Bement W., Lambrecht R., Jacobs J., Sinclair J. Uroporphyria caused by acetone and 5-aminolevulinic acid in iron-loaded mice. Biochem. Pharmacol. 38:1989;4341-4344.
32. Sinclair P., Lambrecht R., Sinclair J. Evidence for cytochrome P450-mediated oxidation of uroporphyrinogen by cell-free liver extracts from chick embryos treated with 3-methylcholanthrene. Biochem. Biophys. Res. Commun. 146:1987;1324-1329.
33. Sinclair P. R., Bement W. J., Bonkovsky H. L., Sinclair J. F. Inhibition of uroporphyrinogen decarboxylase by halogenated biphenyls in chick hepatocyte cultures. Biochem. J. 222:1984;737-748.
34. Sinclair P. R., Bement W. J., Lambrecht R. W., Gorman N., Sinclair J. F. Chlorinated biphenyls induce cytochrome P4501A2 and uroporphyrin accumulation in cultures of mouse hepatocytes. Arch. Biochem. Biophys. 281:1990;225-232.
35. Sinclair P. R., Gorman N., Dalton T., Walton H. S., Bement W. J., Sinclair J. F., Smith A. G., Nebert D. W. Uroporphyria produced in mice by iron and 5-aminolevulinic acid does not occur in Cyp1a2(-/-) null mutant mice. Biochem. J. 330:1998a;149-153.
36. Sinclair P. R., Gorman N., Sinclair J. F., Walton H. S., Bement W. J., Lambrecht R. W. Ascorbic acid inhibits chemically induced uroporphyria in ascorbate-requiring rats. Hepatology. 22:1995;565-572.
37. Sinclair P. R., Gorman N., Tsyrlov I. B., Fuhr U., Walton H. S., Sinclair J. F. Uroporphyrinogen oxidation catalyzed by human cytochromes P450. Drug Metab. Dispos. 26:1998b;1019-1025.
38. Sinclair P. R., Gorman N., Walton H. S., Sinclair J. F., Lee C. A., Rifkind A. B. Identification of CYP1A5 as the CYP1A enzyme mainly responsible for uroporphyrinogen oxidation induced by Ah receptor ligands in chicken liver and kidney. Drug Metab. Dispos. 25:1997;779-783.
39. Smith A. G., Francis J. E. Genetic variation of iron-induced uroporphyria in mice. Biochem. J. 291:1993;29-35.
40. Smith A. G., Francis J. E., Green J. A., Greig J. B., Wolf C. R., Manson M. M. Sex-linked hepatic uroporphyria and the induction of cytochromes P4501A in rats caused by hexachlorobenzene and polyhalogenated biphenyls. Biochem. Pharmacol. 40:1990;2059-2068.
41. Smith A. G., Francis J. E., Kay S. J. E., Greig J. B., Stewart F. P. Mechanistic studies of the inhibition of hepatic uroporphyrinogen decarboxylase in C57BL/10 mice by iron-hexachlorobenzene synergism. Biochem. J. 238:1986;871-878.
42. Sweeney G. D., Jones K. G., Cole F. M., Basford D., Krestynski F. Iron deficiency prevents liver toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin. Science. 204:1979;332-335.
43. Taljaard J., Shanley B., Deppe W., Joubert S. Porphyrin metabolism in experimental hepatic siderosis in the rat. II. Combined effect of iron overload and hexachlorobenzene. Br. J. Hematol. 23:1972;513-519.
44. Torrance J. D., Bothwell T. H. A simple technique for measuring storage iron concentrations in formalised liver samples. S. Afr. J. Med. Sci. 33:1968;9-11.
45. Urquhart J., Elder G. H., Roberts A. G., Lambrecht R. W., Sinclair P. R., Bement W. J., Gorman N., Sinclair J. F. Uroporphyria produced in mice by 20-methylcholanthrene and 5-aminolevulinic acid. Biochem. J. 253:1988;357-362.
46. Van Birgelen A. P. J. M. Hexachlorobenzene as a possible major contributor to the dioxin activity of human milk. Environ. Health Perspect. 106:1998;683-688.
47. Wrighton S., Thomas P., Ryan D., Levin W. Purification and characterization of ethanol-inducible human hepatic cytochrome P450HLj. Arch. Biochem. Biophys. 258:1987;292-297.